Bio-Rad Laboratories (BIO) Gross Margin (2009 - 2026)
Bio-Rad Laboratories (BIO) reported Gross Margin of 52.25% for Q1 2026, down 2.0% year-over-year from 53.32% in Q1 2025, and up 4.93% on a QoQ basis from 49.8% in Q4 2025.
Bio-Rad Laboratories (BIO) has 18 years of Gross Margin data on file, last reported at 52.25% in Q1 2026.
- Quarterly Gross Margin fell 2.0% year-over-year to 52.25% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 51.87% (down 161.0% YoY) and the FY2025 annual result came in at 51.87%, down 186.0% from the prior year.
- Gross Margin rose to 52.25% in Q1 2026 per BIO's latest filing, from 49.8% in the prior quarter.
- Across five years, Gross Margin topped out at 57.51% in Q1 2022 and bottomed at 49.8% in Q4 2025.
- The 5-year median for Gross Margin is 53.36% (2024), against an average of 53.67%.
- The widest annual swing landed in 2022, when Gross Margin jumped 240 bps; it then sank 396 bps in 2023.
- Tracing BIO's Gross Margin over 5 years: stood at 54.37% in 2022, then retreated by 1 bps to 53.77% in 2023, then decreased by 5 bps to 51.24% in 2024, then retreated by 3 bps to 49.8% in 2025, then advanced by 5 bps to 52.25% in 2026.
- Per Business Quant, the three latest BIO Gross Margin figures stand at 52.25% (Q1 2026), 49.8% (Q4 2025), and 52.59% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 43.89% |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn | 52.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.25% |
| Dec 31, 2025 | 49.80% |
| Sep 30, 2025 | 52.59% |
| Jun 30, 2025 | 52.99% |
| Mar 31, 2025 | 52.27% |
| Dec 31, 2024 | 51.24% |
| Sep 30, 2024 | 54.78% |
| Jun 30, 2024 | 55.61% |
| Mar 31, 2024 | 53.36% |
| Dec 31, 2023 | 53.77% |
| Sep 30, 2023 | 53.11% |
| Jun 30, 2023 | 53.22% |
| Mar 31, 2023 | 53.55% |
| Dec 31, 2022 | 54.37% |
| Sep 30, 2022 | 54.73% |
| Jun 30, 2022 | 57.16% |
| Mar 31, 2022 | 57.51% |
| Dec 31, 2021 | 54.57% |
| Sep 30, 2021 | 58.43% |
| Jun 30, 2021 | 56.03% |
| Mar 31, 2021 | 55.10% |
| Dec 31, 2020 | 58.26% |
| Sep 30, 2020 | 56.74% |
| Jun 30, 2020 | 54.57% |
| Mar 31, 2020 | 55.53% |
| Dec 31, 2019 | 52.91% |
| Sep 30, 2019 | 54.76% |
| Jun 30, 2019 | 53.75% |
| Mar 31, 2019 | 56.28% |
| Dec 31, 2018 | 53.91% |
| Sep 30, 2018 | 52.60% |
| Jun 30, 2018 | 52.39% |
| Mar 31, 2018 | 54.80% |
| Dec 31, 2017 | 55.56% |
| Sep 30, 2017 | 55.98% |
| Jun 30, 2017 | 54.17% |
| Mar 31, 2017 | 54.01% |
| Dec 31, 2016 | 55.01% |
| Sep 30, 2016 | 54.94% |
| Jun 30, 2016 | 54.22% |
| Mar 31, 2016 | 56.03% |
| Dec 31, 2015 | 54.07% |
| Sep 30, 2015 | 56.06% |
| Jun 30, 2015 | 55.25% |
| Mar 31, 2015 | 57.13% |
| Dec 31, 2014 | 53.06% |
| Sep 30, 2014 | 54.39% |
| Jun 30, 2014 | 55.37% |
| Mar 31, 2014 | 54.05% |
| Dec 31, 2013 | 53.55% |
| Sep 30, 2013 | 56.27% |
| Jun 30, 2013 | 57.13% |
| Mar 31, 2013 | 54.31% |
| Sep 30, 2012 | 54.90% |
| Jun 30, 2012 | 56.41% |
| Mar 31, 2012 | 57.31% |
| Dec 31, 2011 | 56.52% |
| Sep 30, 2011 | 57.35% |
| Jun 30, 2011 | 56.18% |
| Mar 31, 2011 | 57.23% |
| Dec 31, 2010 | 56.16% |
| Sep 30, 2010 | 56.48% |
| Jun 30, 2010 | 57.37% |
| Mar 31, 2010 | 56.61% |
| Dec 31, 2009 | 54.23% |
| Sep 30, 2009 | 56.50% |
| Jun 30, 2009 | 56.64% |